Brains Bioceutical secures US$ 31.9m from DSM venturing

CANADA – Royal DSM venturing a Dutch multinational corporation active in the fields of health, nutrition and materials has pumped US$ 31.9m worth of investment into Brains Bioceutical corporation during an investment round and capital raise. This major investment was made possible by Del Morgan & Co., an affiliate financial agent of Brains Bioceutical corporation. Brains is among the leading identifiable companies that heavily ventures into cannabinoid (CBD) as an Active Pharmaceutical Ingredient (API) through research, development, production and clinical trials. CBD, an active ingredient in cannabis is derived from…

Read More